[
  {
    "ts": "2025-06-25T17:33:32+00:00",
    "headline": "Stryker (NYSE:SYK) Gains FDA Clearance for Innovative Total Ankle System",
    "summary": "Stryker (NYSE:SYK) recently received FDA clearance for its Incompass® Total Ankle System, a significant product innovation that highlights the company's commitment to advancing patient care. Over the last quarter, Stryker's stock price moved up by 5%, a performance that comfortably exceeds the broader market's 1.9% increase over the same period. While the FDA clearance news likely supported this uptrend, other developments—such as the company's robust Q1 earnings and increased dividend...",
    "url": "https://finance.yahoo.com/news/stryker-nyse-syk-gains-fda-173332492.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "d5b771f4-5f75-3d38-84ae-2752001d1cb5",
      "content": {
        "id": "d5b771f4-5f75-3d38-84ae-2752001d1cb5",
        "contentType": "STORY",
        "title": "Stryker (NYSE:SYK) Gains FDA Clearance for Innovative Total Ankle System",
        "description": "",
        "summary": "Stryker (NYSE:SYK) recently received FDA clearance for its Incompass® Total Ankle System, a significant product innovation that highlights the company's commitment to advancing patient care. Over the last quarter, Stryker's stock price moved up by 5%, a performance that comfortably exceeds the broader market's 1.9% increase over the same period. While the FDA clearance news likely supported this uptrend, other developments—such as the company's robust Q1 earnings and increased dividend...",
        "pubDate": "2025-06-25T17:33:32Z",
        "displayTime": "2025-06-25T17:33:32Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/983f2bdfe32b19227b1d118c45bf4f09",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/vLi2clQ39cq4H4GDgg1AAA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/983f2bdfe32b19227b1d118c45bf4f09.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/hLmZY7hCIZ66l74wpB8KIg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/983f2bdfe32b19227b1d118c45bf4f09.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/stryker-nyse-syk-gains-fda-173332492.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/stryker-nyse-syk-gains-fda-173332492.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "SYK"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-06-25T12:15:00+00:00",
    "headline": "Stryker receives FDA clearance for Incompass Total Ankle System",
    "summary": "PORTAGE, Mich., June 25, 2025--Stryker received FDA 510(k) clearance for its Incompass® Total Ankle System, intended for patients with severe arthritis-related ankle joint damage.",
    "url": "https://finance.yahoo.com/news/stryker-receives-fda-clearance-incompass-121500571.html",
    "source": "Business Wire",
    "provider": "yfinance",
    "raw": {
      "id": "0e644dab-14d3-30df-a629-51bdeed9ec7a",
      "content": {
        "id": "0e644dab-14d3-30df-a629-51bdeed9ec7a",
        "contentType": "STORY",
        "title": "Stryker receives FDA clearance for Incompass Total Ankle System",
        "description": "",
        "summary": "PORTAGE, Mich., June 25, 2025--Stryker received FDA 510(k) clearance for its Incompass® Total Ankle System, intended for patients with severe arthritis-related ankle joint damage.",
        "pubDate": "2025-06-25T12:15:00Z",
        "displayTime": "2025-06-25T12:15:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/business-wire.com/c13a991a872761e8167bf2d57586aa47",
          "originalWidth": 480,
          "originalHeight": 288,
          "caption": "Stryker's Incompass® Total Ankle System integrates the technologies of the Inbone® and Infinity® systems into a single, comprehensive solution.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/dI1u3sEUFVxSpSEkeb_CVg--~B/aD0yODg7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/c13a991a872761e8167bf2d57586aa47.cf.webp",
              "width": 480,
              "height": 288,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Mn.HgmjRJHtz9RmJvoyqRw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/c13a991a872761e8167bf2d57586aa47.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Business Wire",
          "url": "http://www.businesswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/stryker-receives-fda-clearance-incompass-121500571.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/stryker-receives-fda-clearance-incompass-121500571.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "SYK"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-06-25T12:13:00+00:00",
    "headline": "Is ISRG's Procedure Growth Enough to Offset Margin Pressures in 2025?",
    "summary": "Intuitive Surgical raises 2025 procedure outlook after strong Q1 growth, but rising costs and tariff pressure weigh on margins.",
    "url": "https://finance.yahoo.com/news/isrgs-procedure-growth-enough-offset-121300465.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "89f2cb09-50f7-3e7e-920e-ee45433cc2ba",
      "content": {
        "id": "89f2cb09-50f7-3e7e-920e-ee45433cc2ba",
        "contentType": "STORY",
        "title": "Is ISRG's Procedure Growth Enough to Offset Margin Pressures in 2025?",
        "description": "",
        "summary": "Intuitive Surgical raises 2025 procedure outlook after strong Q1 growth, but rising costs and tariff pressure weigh on margins.",
        "pubDate": "2025-06-25T12:13:00Z",
        "displayTime": "2025-06-25T12:13:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/ffe56c6b40972cd987bbb0cf256ae119",
          "originalWidth": 620,
          "originalHeight": 413,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ly2eKWIt2DGVNvSZ_c1.OQ--~B/aD00MTM7dz02MjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/ffe56c6b40972cd987bbb0cf256ae119.cf.webp",
              "width": 620,
              "height": 413,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Jcy0r8Ec0Arq0Msc4P7F2w--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/ffe56c6b40972cd987bbb0cf256ae119.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/isrgs-procedure-growth-enough-offset-121300465.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/isrgs-procedure-growth-enough-offset-121300465.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MDT"
            },
            {
              "symbol": "SYK"
            },
            {
              "symbol": "ISRG"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]